These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 35298610

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Assessing the sensitivity to change of the OMERACT ultrasound structural gout lesions during urate-lowering therapy.
    Christiansen SN, Østergaard M, Slot O, Keen H, Bruyn GAW, D'Agostino MA, Terslev L.
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 32396518
    [Abstract] [Full Text] [Related]

  • 3. The value of musculoskeletal ultrasound in predicting gout flares in index joints: A prospective cohort study of people with gout starting urate-lowering therapy.
    Han L, Li R, Dalbeth N, Liu M, Yu Q, Jiang C, Ning C, Liu Z, He Y, Li M, Xue X, Jia F, Jia Z, Sun W, Zhang H, Lu J, Wang C, Li C.
    Semin Arthritis Rheum; 2024 Aug; 67():152418. PubMed ID: 38422901
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ultrasound Evaluation of Three Outcome Domains in the Follow-up of Urate-Lowering Therapy in Gout: An Observational Study.
    Zhang W, Zhao D, Wu M, Chen W, Jin Z, Zhang H.
    Ultrasound Med Biol; 2021 Jun; 47(6):1495-1505. PubMed ID: 33785225
    [Abstract] [Full Text] [Related]

  • 6. Ultrasound for the diagnosis of gout-the value of gout lesions as defined by the Outcome Measures in Rheumatology ultrasound group.
    Christiansen SN, Østergaard M, Slot O, Fana V, Terslev L.
    Rheumatology (Oxford); 2021 Jan 05; 60(1):239-249. PubMed ID: 32696059
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gout of feet and ankles in different disease durations: diagnostic value of single-source DECT and evaluation of urate deposition with a novel semi-quantitative DECT scoring system.
    Shang J, Li XH, Lu SQ, Shang Y, Li LL, Liu B.
    Adv Rheumatol; 2021 Jun 12; 61(1):36. PubMed ID: 34118994
    [Abstract] [Full Text] [Related]

  • 11. The Role of Ultrasound Semi-Quantitative Scoring in the Diagnosis and Assessment of Gout and Hyperuricemia.
    Shao Q, Wang J.
    J Ultrasound Med; 2024 Feb 12; 43(2):281-291. PubMed ID: 37853928
    [Abstract] [Full Text] [Related]

  • 12. Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study.
    Hammer HB, Karoliussen L, Terslev L, Haavardsholm EA, Kvien TK, Uhlig T.
    Ann Rheum Dis; 2020 Nov 12; 79(11):1500-1505. PubMed ID: 32669301
    [Abstract] [Full Text] [Related]

  • 13. Ultrasonography and dual-energy computed tomography provide different quantification of urate burden in gout: results from a cross-sectional study.
    Pascart T, Grandjean A, Norberciak L, Ducoulombier V, Motte M, Luraschi H, Vandecandelaere M, Godart C, Houvenagel E, Namane N, Budzik JF.
    Arthritis Res Ther; 2017 Jul 21; 19(1):171. PubMed ID: 28732526
    [Abstract] [Full Text] [Related]

  • 14. Two-year reduction of dual-energy CT urate depositions during a treat-to-target strategy in gout in the NOR-Gout longitudinal study.
    Uhlig T, Eskild T, Karoliussen LF, Sexton J, Kvien TK, Haavardsholm EA, Dalbeth N, Hammer HB.
    Rheumatology (Oxford); 2022 Apr 18; 61(SI):SI81-SI85. PubMed ID: 34247224
    [Abstract] [Full Text] [Related]

  • 15. Ultrasonographic Features of Lower-Limb Joints in Gout: Which Joints and Clinical Characteristics Would Provide More Information for Diagnosis?
    Zhang W, Jin Z, Xiang W, Wu M, Wang S, Zhang H, Zhang P.
    J Clin Rheumatol; 2020 Jan 18; 26(1):14-18. PubMed ID: 30234671
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessing Elementary Lesions in Gout by Ultrasound: Results of an OMERACT Patient-based Agreement and Reliability Exercise.
    Terslev L, Gutierrez M, Christensen R, Balint PV, Bruyn GA, Delle Sedie A, Filippucci E, Garrido J, Hammer HB, Iagnocco A, Kane D, Kaeley GS, Keen H, Mandl P, Naredo E, Pineda C, Schicke B, Thiele R, D'Agostino MA, Schmidt WA, OMERACT US Gout Task Force.
    J Rheumatol; 2015 Nov 18; 42(11):2149-54. PubMed ID: 26472419
    [Abstract] [Full Text] [Related]

  • 18. Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking.
    Modjinou DV, Krasnokutsky S, Gyftopoulos S, Pike VC, Karis E, Keenan RT, Lee K, Crittenden DB, Samuels J, Pillinger MH.
    Clin Rheumatol; 2017 Sep 18; 36(9):2101-2107. PubMed ID: 28623421
    [Abstract] [Full Text] [Related]

  • 19. The popliteal groove region: A new target for the detection of monosodium urate crystal deposits in patients with gout. An ultrasound study.
    Di Matteo A, Filippucci E, Cipolletta E, Ausili M, Martire V, Di Carlo M, Salaffi F, Grassi W.
    Joint Bone Spine; 2019 Jan 18; 86(1):89-94. PubMed ID: 30025961
    [Abstract] [Full Text] [Related]

  • 20. UltraSound evaluation in follow-up of urate-lowering therapy in gout phase 2 (USEFUL-2): Duration of flare prophylaxis.
    Ebstein E, Forien M, Norkuviene E, Richette P, Mouterde G, Daien C, Ea HK, Brière C, Lioté F, Petraitis M, Bardin T, Ora J, Dieudé P, Ottaviani S.
    Joint Bone Spine; 2020 Dec 18; 87(6):647-651. PubMed ID: 32979555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.